NCT05135663Active, not recruitingPhase 2
Extension Study of NS-089/NCNP-02 in DMD
A Phase II, Open-Label, Extension Study of NS-089/NCNP-02 in Patients With Duchenne Muscular Dystrophy
Source: ClinicalTrials.gov · Last updated 20 Jul 2025
Brief summary (registry, in English)
This is the extension study of NS-089/NCNP-02 (Study NCNP/DMT02), which is designed to assess the safety, tolerability and efficacy of NS-089/NCNP-02 in patients with Duchenne muscular dystrophy (DMD).
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- First submitted
- 5 Oct 2021
- Start date
- 23 Jun 2021
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- Nippon Shinyaku Co., Ltd.
- Diseases
- Duchenne muscular dystrophy
- NCT number
- NCT05135663
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 6
- From 23 Jun 2021 to the primary completion date, 30 Apr 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient took any other investigational drugs after completion of Study NCNP/DMT02.
Other
- Patient had any serious adverse events in Study NCNP/DMT02 that, in the opinion of the Investigator and/or Sponsor, was probably or definitely related to NS-089/NCNP-02 use and precludes safe use of NS-089/NCNP-02 for the patient in this study.
- Patient had a treatment which was made for the purpose of dystrophin or dystrophin-related protein induction after completion of Study NCNP/DMT02.
- Patient was judged by the investigator and/or the Sponsor that it was not appropriate to participate in the extension study for other reasons.
Who the study is looking for
- Patient completed Study NCNP/DMT02
Sex: Male · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kagoshima University Hospital Coordinator of this site? Confirm its status | Kagoshima | Japan | Unknown status |
| National Center of Neurology and Psychiatry Coordinator of this site? Confirm its status | Tokyo | Japan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.